Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial
<p>Choroideremia is a rare, X-linked retinal degeneration resulting in progressive vision loss. A randomized, masked, phase 3 clinical trial evaluated the safety and efficacy over 12 months of follow-up in adult males with choroideremia randomized to receive a high-dose (1.0&thi...
Main Authors: | MacLaren, RE, Fischer, MD, Gow, JA, Lam, BL, Sankila, E-MK, Girach, A, Panda, S, Yoon, D, Zhao, G, Pennesi, ME |
---|---|
格式: | Journal article |
語言: | English |
出版: |
Springer Nature
2023
|
相似書籍
-
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
由: Han, RC, et al.
出版: (2021) -
Recent advances and future prospects in choroideremia
由: Zinkernagel MS, et al.
出版: (2015-11-01) -
Macular hole surgery in patients with end-stage choroideremia
由: Zinkernagel, MS, et al.
出版: (2013) -
Functional defects in color vision in patients with choroideremia
由: Jolly, J, et al.
出版: (2015) -
Choroideremia: molecular mechanisms and development of AAV gene therapy
由: Patrício, M, et al.
出版: (2018)